Sign inGet started

5AM Co-Investors III, L.P.

Insider CIK 1478660 · EPRS 10% owner · RLYP 10% owner · CDTX 10% owner · BOLD · ARVN 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ARVN ARVINAS, INC. J Other2019-09-162019-09-1885,396— $085,396SEC↗
ARVN ARVINAS, INC. J Other2019-09-162019-09-1811,306— $079,856SEC↗
ARVN ARVINAS, INC. J Other2019-09-162019-09-18438,694— $03,098,567SEC↗
ARVN ARVINAS, INC. J Other2019-09-162019-09-1817,079— $017,079SEC↗
ARVN ARVINAS, INC. J Other2019-09-162019-09-1817,079— $017,079SEC↗
ARVN ARVINAS, INC. J Other2019-09-162019-09-181,002— $01,002SEC↗
ARVN ARVINAS, INC. J Other2019-09-162019-09-188,540— $08,540SEC↗
ARVN ARVINAS, INC. J Other2019-09-162019-09-188,540— $08,540SEC↗
ARVN ARVINAS, INC. S Sale2019-06-282019-07-019,045$22.02 $199.2K91,162SEC↗
ARVN ARVINAS, INC. S Sale2019-06-282019-07-01350,955$22.02 $7.73M3,537,261SEC↗
ARVN ARVINAS, INC. S Sale2019-06-272019-07-01438,694$21.75 $9.54M3,888,216SEC↗
ARVN ARVINAS, INC. S Sale2019-06-272019-07-0111,306$21.75 $245.9K100,207SEC↗
ARVN ARVINAS, INC. S Sale2019-06-072019-06-11185,226$19.65 $3.64M4,326,910SEC↗
ARVN ARVINAS, INC. S Sale2019-06-072019-06-114,774$19.65 $93.8K111,513SEC↗
ARVN ARVINAS, INC. S Sale2019-03-282019-04-01352,056$14.16 $4.99M4,512,136SEC↗
ARVN ARVINAS, INC. S Sale2019-03-282019-04-019,073$14.16 $128.5K116,287SEC↗
ARVN ARVINAS INC. C Conversion deriv2018-10-012018-10-0355,522— $00SEC↗
ARVN ARVINAS INC. C Conversion deriv2018-10-012018-10-03239,776— $00SEC↗
ARVN ARVINAS INC. C Conversion deriv2018-10-012018-10-034,350,709— $00SEC↗
ARVN ARVINAS INC. C Conversion deriv2018-10-012018-10-03112,128— $00SEC↗
ARVN ARVINAS INC. C Conversion deriv2018-10-012018-10-039,303,611— $00SEC↗
ARVN ARVINAS INC. C Conversion deriv2018-10-012018-10-032,154,311— $00SEC↗
ARVN ARVINAS INC. C Conversion2018-10-012018-10-031,338,679— $04,201,328SEC↗
ARVN ARVINAS INC. C Conversion2018-10-012018-10-032,862,649— $02,862,649SEC↗
ARVN ARVINAS INC. C Conversion2018-10-012018-10-03662,864— $04,864,192SEC↗
ARVN ARVINAS INC. C Conversion2018-10-012018-10-0373,777— $073,777SEC↗
ARVN ARVINAS INC. C Conversion2018-10-012018-10-0334,500— $0108,277SEC↗
ARVN ARVINAS INC. C Conversion2018-10-012018-10-0317,083— $0125,360SEC↗
BOLD Audentes Therapeutics, Inc P Buy2017-04-242017-04-264,331$14.50 $62.8K64,431SEC↗
BOLD Audentes Therapeutics, Inc P Buy2017-04-242017-04-26168,082$14.50 $2.44M2,500,113SEC↗
CDTX Cidara Therapeutics, Inc. C Conversion deriv2015-04-202015-04-221,764,195— $00SEC↗
CDTX Cidara Therapeutics, Inc. C Conversion deriv2015-04-202015-04-2245,467— $00SEC↗
CDTX Cidara Therapeutics, Inc. C Conversion2015-04-202015-04-221,764,195— $01,956,099SEC↗
CDTX Cidara Therapeutics, Inc. C Conversion2015-04-202015-04-2245,467— $050,412SEC↗
EPRS EPIRUS Biopharmaceuticals, P Buy2015-02-042015-02-06389,950$5.00 $1.95M2,549,211SEC↗
EPRS EPIRUS Biopharmaceuticals, P Buy2015-02-042015-02-0610,050$5.00 $50.3K65,699SEC↗
RLYP Relypsa Inc S Sale2014-12-092014-12-1114,814$30.04 $445.0K47,502SEC↗
RLYP Relypsa Inc S Sale2014-12-092014-12-11574,823$30.04 $17.27M1,843,243SEC↗
RLYP Relypsa Inc J Other deriv2013-11-202013-11-20102,036— $0102,036SEC↗
RLYP Relypsa Inc J Other deriv2013-11-202013-11-20102,036— $00SEC↗
RLYP Relypsa Inc M Exercise deriv2013-11-202013-11-20442,160— $00SEC↗
RLYP Relypsa Inc J Other deriv2013-11-202013-11-20442,160— $0442,160SEC↗
RLYP Relypsa Inc J Other deriv2013-11-202013-11-20442,160— $00SEC↗
RLYP Relypsa Inc J Other deriv2013-11-202013-11-202,629— $00SEC↗
RLYP Relypsa Inc C Conversion deriv2013-11-202013-11-2031,809— $00SEC↗
RLYP Relypsa Inc C Conversion deriv2013-11-202013-11-20284,822— $00SEC↗
RLYP Relypsa Inc C Conversion deriv2013-11-202013-11-201,234,230— $00SEC↗
RLYP Relypsa Inc J Other deriv2013-11-202013-11-202,629— $02,629SEC↗
RLYP Relypsa Inc M Exercise deriv2013-11-202013-11-202,629— $00SEC↗
RLYP Relypsa Inc M Exercise deriv2013-11-202013-11-20102,036— $00SEC↗
RLYP Relypsa Inc J Other deriv2013-11-202013-11-2011,395— $00SEC↗
RLYP Relypsa Inc J Other deriv2013-11-202013-11-2011,395— $011,395SEC↗
RLYP Relypsa Inc M Exercise deriv2013-11-202013-11-2011,395— $00SEC↗
RLYP Relypsa Inc C Conversion deriv2013-11-202013-11-207,340— $00SEC↗
RLYP Relypsa Inc C Conversion2013-11-202013-11-20284,822— $01,519,052SEC↗
RLYP Relypsa Inc F Tax w/h2013-11-202013-11-2042$11.00 $46252,952SEC↗
RLYP Relypsa Inc M Exercise2013-11-202013-11-202,629$0.17 $44752,994SEC↗
RLYP Relypsa Inc F Tax w/h2013-11-202013-11-20179$11.00 $2.0K50,365SEC↗
RLYP Relypsa Inc M Exercise2013-11-202013-11-2011,395$0.17 $1.9K50,544SEC↗
RLYP Relypsa Inc C Conversion2013-11-202013-11-207,340— $039,149SEC↗
RLYP Relypsa Inc C Conversion2013-11-202013-11-201,234,230— $01,234,230SEC↗
RLYP Relypsa Inc P Buy2013-11-202013-11-209,364$11.00 $103.0K62,316SEC↗
RLYP Relypsa Inc M Exercise2013-11-202013-11-20442,160$0.17 $75.2K1,961,212SEC↗
RLYP Relypsa Inc F Tax w/h2013-11-202013-11-206,914$11.00 $76.1K1,954,298SEC↗
RLYP Relypsa Inc M Exercise2013-11-202013-11-20102,036$0.17 $17.3K2,056,334SEC↗
RLYP Relypsa Inc F Tax w/h2013-11-202013-11-201,596$11.00 $17.6K2,054,738SEC↗
RLYP Relypsa Inc P Buy2013-11-202013-11-20363,328$11.00 $4.00M2,418,066SEC↗
RLYP Relypsa Inc C Conversion2013-11-202013-11-2031,809— $031,809SEC↗